OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Use Associated with Reduced Mortality and Other Disease Outcomes in US Veterans with COVID-19
John G. Rizk, Cachet Wenziger, Diana Tran, et al.
Drugs (2021) Vol. 82, Iss. 1, pp. 43-54
Open Access | Times Cited: 9
John G. Rizk, Cachet Wenziger, Diana Tran, et al.
Drugs (2021) Vol. 82, Iss. 1, pp. 43-54
Open Access | Times Cited: 9
Showing 9 citing articles:
To Anticoagulate or Not to Anticoagulate in COVID-19: Lessons after 2 Years
John G. Rizk, Aashish Gupta, Jose G. Lazo, et al.
Seminars in Thrombosis and Hemostasis (2022) Vol. 49, Iss. 01, pp. 062-072
Closed Access | Times Cited: 14
John G. Rizk, Aashish Gupta, Jose G. Lazo, et al.
Seminars in Thrombosis and Hemostasis (2022) Vol. 49, Iss. 01, pp. 062-072
Closed Access | Times Cited: 14
Ursodeoxycholic acid and COVID-19 outcomes: a cohort study and data synthesis of state-of-art evidence
Yang Yu, Guo‐Fu Li, Jian Li, et al.
Expert Review of Anti-infective Therapy (2024), pp. 1-12
Closed Access | Times Cited: 2
Yang Yu, Guo‐Fu Li, Jian Li, et al.
Expert Review of Anti-infective Therapy (2024), pp. 1-12
Closed Access | Times Cited: 2
Telmisartan and losartan: The marked differences between their chemical and pharmacological properties may explain the difference in therapeutic efficacy in hospitalized patients with COVID‐19
Rodolfo Pedro Rothlin, Facundo Pelorosso, Mariano Duarte, et al.
Pharmacology Research & Perspectives (2023) Vol. 11, Iss. 2
Open Access | Times Cited: 5
Rodolfo Pedro Rothlin, Facundo Pelorosso, Mariano Duarte, et al.
Pharmacology Research & Perspectives (2023) Vol. 11, Iss. 2
Open Access | Times Cited: 5
SARS-CoV-2 and the Angiotensin-Converting Enzyme 2 Receptor: Angiotensin-Converting Enzyme Inhibitor/Angiotensin 2 Receptor Blocker Utilization and a Shift Towards the Renin-Angiotensin-Aldosterone System Classical Pathway
Randy Felber, William New, Suzanne I Riskin
Cureus (2024)
Open Access | Times Cited: 1
Randy Felber, William New, Suzanne I Riskin
Cureus (2024)
Open Access | Times Cited: 1
Association of outpatient use of renin–angiotensin–aldosterone system blockers on outcomes of acute respiratory illness during the COVID-19 pandemic: a cohort study
Molly M. Jeffery, Lucas Oliveira J. e Silva, Fernanda Bellolio, et al.
BMJ Open (2022) Vol. 12, Iss. 7, pp. e060305-e060305
Open Access | Times Cited: 6
Molly M. Jeffery, Lucas Oliveira J. e Silva, Fernanda Bellolio, et al.
BMJ Open (2022) Vol. 12, Iss. 7, pp. e060305-e060305
Open Access | Times Cited: 6
Comparing clinical outcomes of ARB and ACEi in patients hospitalized for acute COVID-19
Seiji Hamada, Tomoharu Suzuki, Yasuharu Tokuda, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 3
Seiji Hamada, Tomoharu Suzuki, Yasuharu Tokuda, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 3
Coronavirus disease 2019, hypertension, and renin–angiotensin–aldosterone system inhibitors
John G. Rizk, Fabián Sanchis‐Gomar, Brandon Michael Henry, et al.
Current Opinion in Cardiology (2022) Vol. 37, Iss. 5, pp. 419-423
Closed Access | Times Cited: 2
John G. Rizk, Fabián Sanchis‐Gomar, Brandon Michael Henry, et al.
Current Opinion in Cardiology (2022) Vol. 37, Iss. 5, pp. 419-423
Closed Access | Times Cited: 2
Uso previo de antagonistas de la angiotensina II en pacientes hipertensos hospitalizados y mortalidad por COVID-19
Teodoro J. Oscanoa, José Amado, Javier Matta-Pérez, et al.
Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo (2022) Vol. 15, Iss. 3, pp. 337-341
Open Access | Times Cited: 1
Teodoro J. Oscanoa, José Amado, Javier Matta-Pérez, et al.
Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo (2022) Vol. 15, Iss. 3, pp. 337-341
Open Access | Times Cited: 1
ACE2: A Dilemma in Regulating SARS-CoV-2 Infection and its Metabolic Complications
Yan‐Chuan Shi
BIO Integration (2022) Vol. 4, Iss. 1
Open Access
Yan‐Chuan Shi
BIO Integration (2022) Vol. 4, Iss. 1
Open Access
